Ra Capital Management, L.P. - Jun 14, 2021 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
HOWL
Transactions as of
Jun 14, 2021
Transactions value $
$4,129,398
Form type
4
Date filed
6/16/2021, 04:58 PM
Previous filing
Jun 10, 2021
Next filing
Jun 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOWL Common Stock Purchase $3.9M +306K +7.71% $12.75 4.27M Jun 14, 2021 See footnotes F1, F2, F7
transaction HOWL Common Stock Purchase $103K +7.96K +0.19% $12.95 4.28M Jun 15, 2021 See footnotes F3, F4, F7
transaction HOWL Common Stock Purchase $124K +9.29K +0.22% $13.37 4.29M Jun 16, 2021 See footnotes F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $12.56 to $12.86; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F2 These securities include 3,830,813 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and 443,825 shares held by RA Capital Nexus Fund II, L.P. ("the Nexus Fund II")
F3 This transaction was executed in multiple trades at prices ranging from $12.53 to $13.00; the price reported above reflects the weighted average purchase price.
F4 These securities include 3,838,771 shares held directly by the Fund and 443,825 shares held by the Nexus Fund II.
F5 This transaction was executed in multiple trades at prices ranging from $12.92 to $13.50; the price reported above reflects the weighted average purchase price.
F6 These securities include 3,848,056 shares held directly by the Fund and 443,825 shares held by the Nexus Fund II.
F7 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.